|
gptkbp:instance_of
|
gptkb:FA_Cup
|
|
gptkbp:affects
|
gptkb:Euphoria
Relaxation
Altered perception
Increased appetite
|
|
gptkbp:casnumber
|
1972-08-3
|
|
gptkbp:chemical_formula
|
C21 H30 O2
|
|
gptkbp:clinical_use
|
Pain relief
Appetite stimulation
Nausea reduction
|
|
gptkbp:composed_by
|
From cannabis plant
|
|
gptkbp:discovered_by
|
gptkb:Raphael_Mechoulam
|
|
gptkbp:discovery_year
|
gptkb:1964
|
|
gptkbp:dissolved
|
Soluble in organic solvents
Poorly soluble in water
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Tetrahydrocannabinol
|
|
gptkbp:isorange
|
gptkb:Cannabigerol_(CBG)
gptkb:Delta-8-THC
gptkb:Cannabidiol_(CBD)
|
|
gptkbp:legal_status
|
Varies by country
|
|
gptkbp:lifespan
|
20-30 hours
|
|
gptkbp:mass
|
314.47 g/mol
|
|
gptkbp:metabolism
|
Liver
|
|
gptkbp:previous_name
|
gptkb:(2_S)-delta-9-tetrahydrocannabinol
|
|
gptkbp:primary_psychoactive_component
|
gptkb:FA_Cup
|
|
gptkbp:receptor_binding
|
gptkb:CB1_receptor
gptkb:CB2_receptor
|
|
gptkbp:related_products
|
gptkb:CBC
gptkb:CBG
gptkb:CBN
gptkb:THCV
THCA
|
|
gptkbp:research_areas
|
Neuroscience
Pain management
Psychoactive substances
Medical cannabis
Appetite stimulation
Cannabinoid pharmacology
|
|
gptkbp:route_of_administration
|
Oral
Topical
Inhalation
Sublingual
|
|
gptkbp:side_effect
|
gptkb:Anxiety
gptkb:Paranoia
Dizziness
Dry mouth
Red eyes
|
|
gptkbp:bfsParent
|
gptkb:Tweed_THC
|
|
gptkbp:bfsLayer
|
6
|